SPS
ALT icon

Susquehanna Portfolio Strategies’s Altimmune ALT Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-135,170
Closed -$488K – 972
2025
Q4 		$488K Sell
135,170
-50,057
-27% -$218K 0.01% 785
2025
Q3 		$698K Buy
185,227
+100,898
+120% +$390K 0.01% 755
2025
Q2 		$326K Buy
+84,329
New +$456K 0.01% 739
2024
Q4 		– Sell
-207,197
Closed -$1.27M – 32
2024
Q3 		$1.27M Hold
207,197
– – 0.09% 173
2024
Q2 		$1.38M Hold
207,197
– – 0.06% 251
2024
Q1 		$2.11M Hold
207,197
– – 0.05% 324
2023
Q4 		$2.33M Buy
+207,197
New +$865K 0.04% 401

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Susquehanna Portfolio Strategies's ALT Position: Q1 2026 in Review

Susquehanna Portfolio Strategies sold out of Altimmune (ALT) in Q1 2026, closing a stake of 135,170 shares — an estimated $488K sold.

Susquehanna Portfolio Strategies first reported a position in ALT in Q4 2023 and held it in 7 quarters. The position peaked at $2.33M in Q4 2023. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Susquehanna Portfolio Strategies reported no remaining Altimmune position as of Q1 2026 after selling out during the quarter.
  • Susquehanna Portfolio Strategies sold 135,170 Altimmune shares in Q1 2026, an estimated $488K.
  • Susquehanna Portfolio Strategies first reported a position in Altimmune in Q4 2023 and held it in 7 quarters.
  • Susquehanna Portfolio Strategies's Altimmune position peaked at $2.33M in Q4 2023.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2026, filed 15 May 2026.